Australia markets closed

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
37.07-0.81 (-2.14%)
At close: 03:00PM CST

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

No.12, Huanglong Third Road
Wuyi County
Jinhua 321200
China
86 57 9876 22285
https://www.sxg1909.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees1,026

Key executives

NameTitlePayExercisedYear born
Mr. Jing XuDeputy GM & DirectorN/AN/A1985
Mr. Hangfeng HuangDirector and Deputy Gen. Mang.N/AN/A1983
Ms. Guofang LiuDeputy GM, Board Sec. & DirectorN/AN/A1976
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale and ganoderma lucidum extract, dendrobium officinale granules, saffron extract, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.

Corporate governance

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.